Dr. Anderson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10903 New Hampshire Ave
Silver Spring, MD 20993
Summary
- Dr. Anderson is a Rheumatologist and Medical Officer in the Division of Rheumatology and Transplant Medicine at the U.S. Food and Drug Administration (FDA). Prior to joining the FDA, he was an Assistant Professor of Medicine in the Division of Rheumatology and Clinical Immunology at the University of Florida.
Education & Training
- University of FloridaFellowship, Rheumatology, 2017 - 2019
- University of FloridaResidency, Internal Medicine, 2014 - 2017
- University of FloridaInternship, Internal Medicine, 2014 - 2015
- Philadelphia College of Osteopathic MedicineClass of 2014
Certifications & Licensure
- MD State License 2019 - 2026
- FL State License 2019 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
- International Society of Clinical Densitometry Certified Clinical Densitometrist
Awards, Honors, & Recognition
- FDA Honor Award Recepient U.S. Food and Drug Administration, 2023
- Resident of the Month University of Florida Shands Hospital, 2017
- Key Award University of Florida Shands Hospital, 2016
Publications & Presentations
PubMed
- 1 citationsUsing Machine Learning to Determine a Suitable Patient Population for Anakinra for the Treatment of COVID-19 Under the Emergency Use Authorization.Qi Liu, Raj Nair, Ruihao Huang, Hao Zhu, Austin Anderson
Clinical Pharmacology and Therapeutics. 2024-04-01 - 3 citationsPrimary antiphospholipid syndrome associated Liebman-Sachs endocarditis leading to diffuse alveolar hemorrhage: A case report.Ryan Hyde, Martin Runnstrom, Austin Anderson, Leonard Riley, Ali Ataya
Respiratory Medicine Case Reports. 2018-01-01 - 58 citationsSoluble CD27-Pool in Humans May Contribute to T Cell Activation and Tumor ImmunityJianping Huang, Caroline Jochems, Austin M. Anderson, Tara Talaie, Alessandra Jales
Journal of Immunology. 2013-05-15
Books/Book Chapters
Press Mentions
- FDA Gives Updates on Newly Approved Agents for Rheumatic DiseasesNovember 17th, 2024
- FDA to Review New Rheumatology Approvals, Safety Messaging, ProgramsNovember 8th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: